Lexicon Pharmaceuticals | Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Abbott USD 3.13B 125M 2025-12
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 41.27M 4.6M 2025-09
Akebia Therapeutics USD 25.74M 1.93M 2025-03
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
AstraZeneca USD 4.61B 4.46B 2025-12
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Coherus Biosciences USD 26.02M 8.57M 2025-03
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Halozyme Therapeutics USD 37.53M 4.53M 2025-09
Illumina USD 283M 27M 2025-12
Insmed USD 186.38M 109.94M 2025-09
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
J&J USD 6.75B 831M 2025-12
Lexicon Pharmaceuticals USD 39.19M 7.13M 2024-06
MacroGenics USD 9.9M 600K 2025-09
MannKind USD 29.09M 2.53M 2025-09
Merck USD 2.85B 215M 2025-12
Moderna USD 268M 38M 2025-09
Novartis USD 3.31B 134M 2025-09
PTC Therapeutics USD 84.05M 1.22M 2025-09
Puma Biotechnology USD 16.82M 8.15M 2024-09
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Thermo Fisher Scientific USD 1.98B 182M 2025-12
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
United Therapeutics USD 152M 60.5M 2025-09
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12


Lexicon Pharmaceuticals Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.